Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

SHL shares: your next growth investment?

The Sonic Healthcare Ltd (ASX:SHL) share price is down 14.9% since the start of 2024. It's probably worth asking, 'is the SHL share price undervalued?'
The Sonic Healthcare Ltd (ASX:SHL) share price is down 14.9% since the start of 2024. At the same time, the Brambles Ltd (ASX:BXB) share price is 2.1% away from its 52-week high. This brief article explains why it could be worth adding SHL and BXB shares to your ASX investing stock watchlist.

SHL share price in focus

Sonic Healthcare, listed in April 1987, has grown into one of the world’s largest pathology businesses, with operations spanning Australia, New Zealand, Europe, and North America.

The company provides a wide range of services, including laboratory medicine, pathology, diagnostic imaging, radiology, general practice medicine, and corporate medical services.

Sonic Healthcare is committed to prioritizing the needs of doctors and their patients, striving for medical excellence while fostering a supportive and desirable workplace.

BXB shares

Brambles manages the world’s largest pool of reusable pallets, crates, and containers, providing a service central to most supply chains globally.

The company is better known by its main brand CHEP, which has operations across the Asia-Pacific, Americas, and Europe Middle East and Africa (EMEA) regions.

Brambles makes money through a hiring model. For example, a manufacturer will make a product, then transfer the product to a retailer on CHEP pallets. Those pallets are then transferred back to CHEP or to another manufacturer or retailer in the supply chain. At each step, Brambles collects daily hire fees on its pallets and crates.

SHL share price valuation

As a growth company, some of the trends we might investigate from SHL include revenue growth, profit growth, and return on equity (ROE). These measures can indicate the growth rates and prospects of the company, as well as their ability to generate returns from their assets.

Since 2021, SHL has grown revenue at a rate of 0.8% per year to reach $8,967m in FY24. Over the same stretch of time, net profit has fallen from $1,315m to $511m. SHL last reported a ROE of 6.8%.

Since BXB is more of a ‘mature’ or ‘blue-chip’ business, some of the metrics that could be considered important include the debt/equity ratio, average yield, and return on equity, or ROE. These are useful as they give us an idea of debt levels and the company’s ability to generate a return on assets and pay out profits (which is what we want from a blue chip). In FY24, Brambles Ltd reported a debt/equity ratio of 81.8%, meaning the company has more equity than debt.

As for dividends, since 2019 BXB has achieved an average dividend yield of 2.7% per year.

Finally, in FY24, BXB reported an ROE of 25.6%. For a mature business you’re generally looking for an ROE of more than 10%, so BXB clears this hurdle.

It’s important to keep in mind that these are only a small selection of metrics and don’t give us enough information to value the business or make an investment decision. To learn more about valuation, check out one of our free online investing courses.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

5%+ in passive income

Owen Rask’s investing report available

With bond ETFs like ASX:IAF and the S&P 500 riding high, now could be one of the best times to start earning passive income from a portfolio of shares and ETFs.

In this free analyst report, our Chief Investment Officer, Owen Rask, names 10 ASX stocks and ETFs to watch.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Skip to content